INTELLIPHARMACEUTICS CORP has a total of 13 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and environmental technology are ORIGINAL BIOMEDICALS CO LTD, JILIN AODONG GROUP DALIAN PHARMACEUTICAL CO LTD and STEM CELL THERANOSTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Odidi Isa | 13 |
#2 | Odidi Amina | 13 |
Publication | Filing date | Title |
---|---|---|
AU2002325118A1 | Combinatorial type (several vehicles within a housing) controlled release drug delivery device | |
US6676966B1 | Extended release metformin hydrochloride formulations | |
US6800668B1 | Syntactic deformable foam compositions and methods for making | |
US6652882B1 | Controlled release formulation containing bupropion | |
US7906143B1 | Controlled release pharmaceutical delivery device and process for preparation thereof |